Lupin Diagnostics Achieves 100% NABL Accreditation Across All Greenfield Labs
Lupin Diagnostics Limited (LDL), the diagnostics arm of pharma major Lupin Limited, has announced a significant milestone with all its […]
Lupin Diagnostics Limited (LDL), the diagnostics arm of pharma major Lupin Limited, has announced a significant milestone with all its […]
Pharma Major Lupin has appointed one of its co-founders Manju Deshbandhu Gupta as chairman of the company for a period […]
The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine […]
Lupin pharmaceuticals has inked a pact to acquire an additional 40 percent stake in South Africa’s Pharma Dynamics, taking its […]
Close on the heels of announcing its foray in the orthopaedic segment, Lupin Limited, has announced the availability of Hyalgan, a therapy against degenerative joint disease-osteoarthritis, in India.
Apollo Hospitals Group has joined hands with Lupin Limited, a leading pharma major, to create the first Disease Management Programme (DMP) for Bronchial Asthma and COPD (Chronic Bronchitis) in the name of Apollo’s ‘BreatheEasy Clinic’.
Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News